CompletedNCT04866043
How Vyvanse is prescribed for binge eating in Australia
About this title
Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder
Read the official source — NCT04866043Observational studyAges 18–55AustraliaEating disorders
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- SydneySee all locations and recruitment
Study information
Study start dateStarted: June 1, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 150
- Sponsor
- Shire
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Australia
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT04866043
- Official title
Show the full official title
Drug Utilization Study With VYVANSE® in Australia for Binge Eating Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Sydney
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Shire.
Who was this study for?
Listed age limits: 18 years to 55 years.
